| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 127, 3151-3159, Copyright © 1990 by Endocrine Society
ARTICLES |
CV Clevenger, AL Sillman and MB Prystowsky
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104.
The nuclear translocation of PRL is demonstrated at the immunofluorescence and electron microscopic (EM) levels in interleukin- 2 (IL2)-stimulated cloned T-cells and concanavalin A-stimulated splenocytes. This translocation occurs 2-10 h after IL2 stimulation, and is reversed by the addition of anti-PRL antiserum into the extracellular culture medium. The nuclear localization of PRL in IL2 stimulated T-cells was confirmed by postembedding immunogold EM. The nuclear uptake of PRL after IL2 stimulation was further documented by EM studies using PRL-colloidal gold conjugates. These studies suggest that the intranuclear PRL is translocated from the extracellular medium via an endosomal/lysosomal pathway over a period of several hours. Finally, the requirement for PRL no later than 6 h after IL2 stimulation is demonstrated through the reversible inhibition of T-cell growth with anti-PRL antiserum.
This article has been cited by other articles:
![]() |
C. V. Clevenger Roles and Regulation of Stat Family Transcription Factors in Human Breast Cancer Am. J. Pathol., November 1, 2004; 165(5): 1449 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ito, M. Nakasato, T. Suzuki, S. Sakai, M. Nagata, and F. Aoki Localization of Janus Kinase 2 to the Nuclei of Mature Oocytes and Early Cleavage Stage Mouse Embryos Biol Reprod, July 1, 2004; 71(1): 89 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Rycyzyn and C. V. Clevenger The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer PNAS, May 14, 2002; 99(10): 6790 - 6795. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Rycyzyn, S. C. Reilly, K. OMalley, and C. V. Clevenger Role of Cyclophilin B in Prolactin Signal Transduction and Nuclear Retrotranslocation Mol. Endocrinol., August 1, 2000; 14(8): 1175 - 1186. [Abstract] [Full Text] |
||||
![]() |
R. Re The Nature of Intracrine Peptide Hormone Action Hypertension, October 1, 1999; 34(4): 534 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Leav, F. B. Merk, K. F. Lee, M. Loda, M. Mandoki, J. E. McNeal, and S.-m. Ho Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions Am. J. Pathol., March 1, 1999; 154(3): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Perrot-Applanat, O Gualillo, H Buteau, M Edery, and P. Kelly Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation J. Cell Sci., January 5, 1997; 110(9): 1123 - 1132. [Abstract] [PDF] |
||||
![]() |
C. Clevenger, S. Altmann, and M. Prystowsky Requirement of nuclear prolactin for interleukin-2--stimulated proliferation of T lymphocytes Science, July 5, 1991; 253(5015): 77 - 79. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |